Presentation Information
[3S03a-07]Closing Remarks
○Atsushi Okabe1,2 (1.Health and Disease Omics Center, Chiba University, 2.Department of Molecular Oncology, Graduate School of Medicine, Chiba University, 3.Division of Microbiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 4.Department of Microbiology, Shimane University Faculty of Medicine, 5.Cancer and Stem Cell Biology Program, Duke-NUS Medical School)
Comment
To browse or post comments, you must log in.Log in